Mekanar Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.75 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Mekanar Pharma
Mekanar Pharma Private Limited (MPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 June 2022 (Two years and eight months 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.75 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Metta, Kathyayini Pasthula, Jwala Darsi, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304TG2022PTC163523
- Company No.
163523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2022
- Date of AGM
16 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Mekanar Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Metta  | Managing Director | 09-Jun-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kathyayini Pasthula | Whole-Time Director | 09-Jun-2022 | Current |
| Jwala Darsi | Whole-Time Director | 09-Jun-2022 | Current |
| Nageswara Mekala | Additional Director | 24-Feb-2023 | Current |
Financial Performance of Mekanar Pharma.
Mekanar Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mekanar Pharma?
Unlock access to Mekanar Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mekalas Ventures LlpNageswara Mekala is a mutual person
- Mnsafety&Hygienics Private Limited
Nageswara Mekala is a mutual person
- Mekalas Spicecloud Private Limited
Nageswara Mekala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mekanar Pharma?
Mekanar Pharma has a workforce of 10 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mekanar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mekanar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.